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ABSTRACT
Sleeping Beauty (SB) is the most active Tc1/
mariner-type transposon in vertebrates. SB contains
two transposase-binding sites (DRs) at the end of
each terminal inverted repeat (IR), a feature termed
the IR/DR structure. We investigated the involve-
ment of cellular proteins in the regulation of SB
transposition. Here, we establish that the DNA-
bending, high-mobility group protein, HMGB1 is
a host-encoded cofactor of SB transposition.
Transposition was severely reduced in mouse cells
de®cient in HMGB1. This effect was rescued by
transient over-expression of HMGB1, and was
partially complemented by HMGB2, but not with the
HMGA1 protein. Over-expression of HMGB1 in wild-
type mouse cells enhanced transposition, indicating
that HMGB1 can be a limiting factor of transposition.
SB transposase was found to interact with HMGB1
in vivo, suggesting that the transposase may recruit
HMGB1 to transposon DNA. HMGB1 stimulated
preferential binding of the transposase to the DR
further from the cleavage site, and promoted bend-
ing of DNA fragments containing the transposon IR.
We propose that the role of HMGB1 is to ensure that
transposase±transposon complexes are ®rst formed
at the internal DRs, and subsequently to promote
juxtaposition of functional sites in transposon
DNA, thereby assisting the formation of synaptic
complexes.
INTRODUCTION
The use of transposable elements as genetic tools contributed
signi®cantly to our understanding of biological systems. In
vertebrates, such tools could be applied to both research and
therapeutics. Tc1/mariner elements are probably the most
widespread transposons in nature (1). These elements are able
to transpose in species other than their hosts, and are therefore
emerging tools for functional genomics in several organisms
(1). However, the vast majority of naturally occurring Tc1/
mariner-like transposons are non-functional due to inactivat-
ing mutations. In vertebrates, not a single active element has
been found. Based on a comparative phylogenetic approach,
we have reconstructed an active Tc1-like transposon from bits
and pieces of inactive elements found in the genomes of
teleost ®sh, and named this transposon Sleeping Beauty (SB)
(2).
SB is ¯anked by ~230 bp terminal inverted repeats (IRs),
which contain binding sites for the enzymatic factor of
transposition, the transposase. The transposase binding sites
(DRs) of SB elements are repeated twice per IR in a direct
orientation (2). This special organization of IR, termed IR/DR,
is an evolutionarily conserved feature of a group of Tc1-like
transposons, but not that of the Tc1 element itself (1,3). In
addition to the DRs, the left IR of SB contains a transpositional
enhancer-like sequence, termed HDR (4). Speci®c binding to
the DRs is mediated by an N-terminal, paired-like DNA-
binding domain of the transposase (2,4,5). The catalytic
domain of the transposase, responsible for the DNA cleavage
and joining reactions, is characterized by a conserved amino
acid triad, the DDE motif, which is found in a large group of
recombinases (6), including retroviral integrases and the
RAG1 V(D)J recombinase involved in immunoglobulin gene
rearrangements (1).
SB transposes via a DNA intermediate, through a cut-and-
paste mechanism. The transposition process can arbitrarily be
divided into at least four major steps: (i) binding of the
transposase to its sites within the transposon IRs; (ii)
formation of a synaptic complex in which the two ends of
the elements are paired and held together by transposase
subunits; (iii) excision from the donor site; (iv) reintegration at
a target site. On the molecular level, mobility of DNA-based
transposable elements can be regulated by imposing con-
straints on transposition. One important form of transposi-
tional control is represented by regulatory `checkpoints', at
which certain molecular requirements have to be ful®lled for
the transpositional reaction to proceed. These requirements
can operate at any of the four different stages of transposition
listed above, and can be brought about by both element- and
host-encoded factors.
Several DNA recombination reactions are stimulated by
DNA-bending proteins. For example, the transposase bind-
ing sites of bacteriophage Mu are brought together by the
bending action of the Escherichia coli HU protein (7). Hin
recombinase-mediated recombination and bacteriophage l
integration are strongly stimulated by HU (8) and integration
host factor (IHF) (9), respectively. The eukaryotic high
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mobility group (HMG) proteins can functionally replace HU
and IHF in some recombination reactions, indicating some
level of exchangeability between these DNA-bending proteins
(10). All of these DNA-bending proteins are believed to assist
recombinational mechanisms by facilitating the formation of
active recombinase±DNA complexes (11,12).
HMG proteins are classi®ed into three subfamilies,
HMGB1/2 (formerly known as HMG1/2), HMGA1a/b (for-
merly known as HMGI/Y) and HMGN1/2 (formerly known as
HMGB14/17, that share many physical characteristics, but
differ in their main functional domains (13). Both the HMGB
and HMGA1 group proteins are known to bind A/T-rich DNA
through interactions with the minor groove of the DNA helix
(12). HMGB1 is an abundant (~106 molecules/cell), non-
histone, nuclear protein associated with eukaryotic chromatin
(12). Through its DNA-binding domain, termed the HMG-
box, HMGB1 binds DNA in a sequence-independent manner,
but with preference for certain DNA structures including four-
way junctions and severely undertwisted DNA (13±16).
HMGB1 has low af®nity to B-form DNA, and is thought to
be recruited by other DNA-binding proteins through protein±
protein interactions, and induce a local distortion of the DNA
upon binding. The ability of HMGB1/2 proteins to bend DNA
was demonstrated in vitro (13). These proteins facilitate self-
ligation of short DNA fragments (17,18), and can bridge linear
DNA fragments thereby enhancing multimerization of longer
DNAs (19). Together with the closely related HMGB2
protein, HMGB1 has been implicated in a number of
eukaryotic cellular processes including gene regulation,
DNA replication and recombination (12,20). HMGB1/2
directly interact with a number of proteins, including some
HOX (21) and POU domain (22) transcription factors and the
TATA-binding protein (23), and facilitate their binding
through protein±protein interactions. HMGB1/2 were shown
to enhance immunoglobulin V(D)J recombination by enfor-
cing speci®c DNA recognition (24) through their interaction
with the RAG1/2 recombinase complex (25), and facilitating
cleavage (24). In addition, HMGB1 was found to promote Rep
protein-mediated site-speci®c cleavage of adeno-associated
virus DNA (26). The production of retroviral cDNA does not
require an excision step, but the downstream events of
retroviral integration are highly similar to other transpositional
reactions (27). Interestingly, HMGA1 family members, but
not HMGB1/2, are required for retroviral cDNA integration
(28,29). Both V(D)J recombination and retroviral integration
have common features with SB transposition. RAG-mediated
cleavage at the ends of recombination signal sequences (RSSs)
in V(D)J recombination is probably analogous to the excision
step of transposition, whereas the biochemical steps leading to
insertion of signal molecules, retrovirus integration and DNA
transposition are essentially the same (27).
SB mediates transposition in a variety of vertebrate species
(30), and is more active than other members of the Tc1/
mariner family (31). Because there is substantial interest in
developing transposon technology for gene therapy (32) and
gene discovery (31), it is of importance to dissect the
molecular mechanisms involved in transposition and its
regulation. In particular, differential interactions between the
transposon and host-encoded factors may result in limitation
of host range. In this work, we evaluated HMG proteins as
cellular host factors of SB transposition in mammalian cells.
We have found that HMGB1 is required for ef®cient SB
transposition. SB transposition was signi®cantly reduced in
HMGB1-de®cient mouse cells. This effect was fully comple-
mented by expressing HMGB1, partially by expressing
HMGB2, but not with HMGA1. Interestingly, transient
over-expression of HMGB1 in wild-type mouse cells
enhanced transposition, indicating that HMGB1 is a limiting
factor of transposition. SB transposase was found to interact
with HMGB1 in vivo, suggesting that the transposase may
actively recruit HMGB1 to transposon DNA via protein±
protein interactions. HMGB1 enhanced preferential binding of
the SB transposase to the internal transposase binding sites
within the transposon IRs, and promoted bending of DNA
fragments comprising the transposon IRs. These data are
consistent with a role of HMGB1 in synaptic complex
formation in transposition.
MATERIALS AND METHODS
Protein expression, puri®cation and electrophoretic
mobility shift assay (EMSA)
Production of N123 was done as described (2). A plasmid
expressing a hexahistidine-tagged version of HMGB1 was
described in Aidinis et al. (25), and was kindly provided by M.
Bianchi, Milan, Italy. Protein expression was induced by the
addition of 0.4 mM IPTG in E.coli BL21 cells. Puri®cation
was done using a nickel resin (Qiagen), according to the
manufucturer's protocol. The puri®ed protein was dialyzed
against 25 mM HEPES pH 7.4, 10% glycerol, 1 M NaCl and
2 mM b-mercaptoethanol, and its concentration determined by
sodium dodecyl sulphate (SDS)±polyacrylamide gel electro-
phoresis.
The plasmid expressing a maltose-binding protein
(MBP)±SB transposase fusion protein was made by cloning
the SB transposase gene into the XmnI/EcoRI sites of pAML-
c2X (NEB). The plasmid was transformed into the BL21-
CodonPlus-RIL E.coli strain (Stratagene). Protein puri®cation
protocol was as described by the manufacturer of the amylose
resin (NEB). A 1 l bacterial culture was grown to OD (A600)
~0.5, IPTG was added to a ®nal concentration of 0.3 mM, and
further incubated at 37°C for 2 h. Cells were harvested and
resuspended in 30 ml of column buffer (CB = 20 mM Tris
pH 7.4, 200 mM NaCl, 1 mM EDTA and 1 mM DTT). Before
cell lysis, 0.6 mg DNase I and 0.5% (v/v) polyethyleneimine
was added. Cell lysis was done by French press at 1200 p.s.i.,
and the pellet obtained after centrifugation was resuspended in
50 ml CB containing 750 mM NaCl. In the higher ionic
strength buffer, MBP±SB was dissolved, but nucleic acids and
some other proteins remained in the pellet. The supernatant
was diluted 1:5 with CB and loaded on an amylose resin
column (12 ml of resin equilibrated with column buffer) with a
¯ow rate not exceeding 1 ml/min. Washing was done with
12 column vol of wash buffer (CB with 750 mM NaCl). The
fusion protein was eluted with elution buffer (20 mM Tris pH
7.4, 750 mM NaCl, 1 mM EDTA, 1 mM DTT and 10 mM
maltose), 25 fractions of 2 ml each were collected; the
fractions having the fusion protein were pooled and concen-
trated to 0.4 mg/ml.
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An EcoRI fragment comprising the left IR of the SB element
containing both transposase binding sites, an A¯II/HindIII
fragment containing only the inner DR (IDR), and an EcoRI/
HindIII fragment of a modi®ed SB element lacking the IDR,
and thus containing only the outer DR (ODR) (30), were end-
labeled using [a32P]dATP and Klenow. Equal amounts of
DNA fragments were used for labeling. Nucleoprotein com-
plexes were formed in 20 mM HEPES (pH 7.5), 0.1 mM
EDTA, 0.1 mg/ml BSA, 150 mM NaCl, 1 mM DTT in a total
volume of 10 ml. Reactions contained ~0.08 nM DNA probe,
1 mg poly(dI)(dC), 75 nM HMGB1 and 0.2, 0.1 or 0.05 ng
N123. Reactions with MBP±SB transposase fusion contained
~0.1 nM of left IR probe (EcoRI fragment) and either 2 nM or
20 nM of puri®ed MBP±SB with or without 0.1 or 1 mM of
puri®ed HMGB1. After a 15 min incubation on ice, 5 ml of
loading dye containing 50% glycerol and bromophenol blue
was added, and the samples loaded onto a 5% polyacrylamide
gel. Radioactive bands were quanti®ed using a Molecular
Dynamics PhosphorImager System.
Ligase-mediated circularization assay
A 32P-labeled left IR fragment (~0.04 nM) with cohesive
EcoRI ends was pre-incubated with 6 nM HMGB1 on ice for
20 min in T4 DNA ligase buffer, in a ®nal volume of 50 ml.
The ligation reaction was initiated by the addition of 0.025 U
of T4 DNA ligase (NEB), and incubated at 16°C. Aliquots of
9 ml of the reaction mixture were withdrawn at different time
points (0, 5, 15, 30 and 60 min), and were added to 41 ml of
stop solution (0.5% SDS, 10 mM EDTA, 1 mg/ml Proteinase
K). The reactions were incubated at 50°C for 2 h, extracted
with phenol/chloroform/isoamyl alcohol, and then with
chloroform/isoamyl alcohol. Aliquots of 30 ml of the 60 min
sample were taken, and digested with 100 U of Exonuclease
III (ExoIII) (NEB) at 37°C for 30 min. Aliquots of 25 ml of
each extracted sample were run on a 4% non-denaturing
polyacrylamide gel, gels were dried and autoradiographed at
±80°C.
For bacterial transformations, ~0.1 nM linearized tran-
sposon DNA was pre-incubated with 12 nM HMGB1, then
1 U/reaction of the T4 DNA ligase was added, and the reaction
allowed to proceed for 0, 15, 30 and 60 min. Reactions were
terminated by the addition of stop solution, the DNA was
precipitated, resuspended in TE, and electroporated into
DH10B E.coli cells.
Immunoprecipitation
Nuclear extracts from ~2.0 3 107 IRES-SB and IRES-K cells
were prepared essentially as described previously (30). The
nuclear extract was diluted to contain 100 mM NaCl with
binding buffer [25 mm HEPES±KOH pH 7.9, 1.5 mM MgCl2,
10 mm KCl, 0.5 mM EDTA, 0.2 mM DTT, 0.1 mM NP-40,
12% glycerol, 13 complete protease inhibitors (Roche)]. For
the DNase I treatment, MgCl2 concentration was increased to
6 mM and 6 U of DNase I (Ambion) was added. The extract
was incubated at 23°C for 30 min, followed by the addition of
2 ml of 500 mM EDTA. The extract was precleared in two
steps, ®rst by adding 1 mg mouse IgG and 20 ml Protein
G-Sepharose (50% slurry in PBS) for 60 min at 4°C, and then
by adding 50 ml Protein G-Sepharose followed by an overnight
incubation at 4°C. Immunoprecipitation was performed using
1 mg HMGB1 antibody (Santa Cruz Biotech.), or actin
antibody (clone ACTN05, Neomarkers), or p15 antibody (R-
20, Santa Cruz Biotech.), or goat preimmune serum (Sigma)
and 15 ml Protein G-Sepharose (50% slurry in PBS). The tubes
were rotated overnight at 4°C. The beads were washed four
times in PBS, resuspended in SDS sample buffer, and
subjected to western hybridization with a rabbit polyclonal
antibody against the SB transposase.
Co-immunoprecipitation was done using puri®ed HMGB1
(1 mM) and puri®ed MBP±SB (0.2 mM), either alone or
together in 20 ml ®nal volume in binding buffer containing
25 mM HEPES (pH 7.5), 10 mM MgCl2, 1 mM DTT, 2%
glycerol, 0.25 mg BSA, 50 mM KCl, 0.01% NP-40 for 20 min
at 4°C. Then ~1 nM of a 32P-labeled transposon fragment
containing the left IR (~120 000 c.p.m.) was added, and the
reaction continued for a further 45 min. One microgram of
either anti-HMGB1 or anti-SB was added, and the incubation
continued for 2 h at 4°C with rotation. Protein A- and Protein
G-Sepharoses were pretreated with the binding buffer con-
taining 500 mg/ml of herring sperm DNA overnight. An
aliquot of 50 ml pretreated Protein A-Sepharose was added to
the anti-SB samples, 50 ml of pretreated Protein G-Sepharose
was added to the anti-HMGB1 samples, and incubation
continued for 3 h at 4°C. The immunoprecipitate was washed
three times with the binding buffer. Radioactivity of the DNA
that remained bound to the beads was quanti®ed with a liquid
scintillation counter.
Cell culture and in vivo transposition assay
Cell lines were grown in DMEM supplemented with 10% fetal
bovine serum. Wild-type (VA1) and HMGB1-de®cient (C1)
mouse embryonic ®broblast (MEF) cell lines have been
described previously (33), and were kindly provided by
M. Bianchi, Milan, Italy. All DNA transfections were done
with FUGENE6 transfection reagent (Roche, Germany). Cells
were cotransfected with 90 ng each of pCMV-SB (2) and
pT/zeo, (30) and 500 ng plasmid expressing HMGB1 (25),
HMGB2 (25), HMGA1 (34) or b-galactosidase. 105 trans-
fected cells were plated out for selection, using 100 mg/ml
zeocin (Invitrogen). After 3 weeks of selection, colonies were
stained and counted as described previously (2).
Transfectability of the C1 cell line is lower than that of the
VA1 line, which was determined by transfection of a GFP-
expressing plasmid. Therefore, transpositional ef®ciencies in
the two cell lines presented in Figure 1B have been normalized
to transfection ef®ciencies.
RESULTS
HMGB1 is required for ef®cient SB transposition in
mouse cells
We assessed the importance of HMGB1 for SB transposition
by applying an in vivo transposition assay (2) on wild-type and
HMGB1-de®cient mouse cells (Fig. 1). The assay is based on
cotransfection of a donor plasmid carrying a zeocin resistance
gene (zeo)-marked transposon and a transposase-expressing
helper plasmid into cultured cells (Fig. 1A). In control
experiments, a plasmid expressing b-galactosidase (CMVb)
substitutes for the transposase helper plasmid. Cells are placed
under antibiotic selection, and the numbers of resistant
colonies counted. The ratio between numbers obtained in the
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presence versus the absence of transposase is the read-out of
the assay, and is a measure of the ef®ciency of transposition.
Consistent with our earlier ®ndings (30), transposition was
readily detectable in the wild-type MEF cell line VA1 (~3-fold
increase in colony number in the presence of transposase)
(Fig. 1B). However, colony numbers obtained in HMGB1-
de®cient C1 cells were not signi®cantly different in the
presence and absence of transposase, indicating a severe drop
in transposition ef®ciency. In order to con®rm that the effect is
speci®c for the lack of HMGB1 protein in C1 cells, a plasmid
expressing human HMGB1 was cotransfected together with
the transposon vectors. Exogenous over-expression of
HMGB1 increased colony numbers ~4-fold (Fig. 1B), which
not only rescues but exceeds wild-type transpositional rates.
The effect of HMGB1 in this experiment is speci®c for the
transposition reaction, because in the absence of transposase
HMGB1 did not increase the number of zeo-resistant colonies
in the C1 cell line (data not shown). We tested the speci®city
of complementation by cotransfecting plasmids expressing
two other members of the HMG family, HMGB2 and
HMGA1. HMGB2 showed partial complementation, consist-
ent with its structural similarity and functional overlap with
HMGB1 (12,13), whereas HMGA1 had no signi®cant effect
on the ef®ciency of transposition (Fig. 1B).
Transient over-expression of HMGB1 in wild-type cells
was shown to enhance the biological activity of several
proteins that interact with HMGs, including the V(D)J
recombinase RAG1/2 (25). Therefore, we cotransfected
wild-type MEFs with the transposon system together with
plasmids expressing HMGB1, HMGB2 or HMGA1. A pattern
of transpositional enhancement similar to that in the HMGB1-
de®cient C1 cell line was observed: HMGB1 had the most
pronounced effect by increasing transposition ~2.5-fold
(Fig. 1B). Over-expression of HMGB2 had a smaller effect,
and increased the numbers of resistant colonies by ~1.5-fold,
whereas overexpressing HMGA1 resulted in no change in
colony numbers (Fig. 1B). Taken together, these results
establish that HMGB1 is required for ef®cient DNA trans-
position in mouse cells, and that HMGB1 is a limiting factor of
transposition in wild-type cells.
Figure 1. Ef®cient SB transposition requires HMGB1. (A) Schematic representation of the in vivo transposition assay. Constructs expressing HMG proteins
are cotransfected with transposon donor and transposase-expressing helper plasmids into cultured cells. In control transfections, a plasmid expressing
b-galactosidase is cotransfected. Cells are placed under zeocin selection, and resistant colonies are counted. The ratio of colony numbers in the presence
versus in the absence of transposase is a measure of the ef®ciency of transposition. Arrows ¯anking the zeocin gene in the transposon donor construct
represent the terminal IRs. (B) The effect of HMG proteins for transposition. HMG protein expressing constructs were cotransfected into either wild-type
(black columns) or HMGB1-de®cient (gray columns) mouse cells. The indicated constructs were used either to complement or to over-express different HMG
proteins. The ef®ciency of transgene integration was estimated by counting zeo-resistant colonies. The numbers on the left represent the numbers of colonies
per 105 cells plated.
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HMGB1 enhances bending of the SB transposon
terminal IR and the full length transposon
Upon binding to DNA, HMG proteins induce conformational
changes in the DNA, thereby facilitating juxtaposition of
distantly bound proteins and assembly of multiprotein com-
plexes (11,12). SB has two transposase-binding sites per
terminal IR, separated by ~160 bp spacer regions. We
hypothesized that the bending activity of HMGB1 could
contribute to bringing the DRs and/or the complete IRs closer
in space, thereby assisting the formation and/or stabilization of
a synaptic complex.
To address this question, a ligase-mediated circularization
assay (18) was performed on a DNA fragment comprising the
left IR of the transposon. This assay measures the effect of
HMGB1 on intramolecular ligation (circularization) of rela-
tively short, and thus rigid, linear DNA molecules. The
bending activity of HMGB1 results in enhanced juxtaposition
of DNA ends, and therefore in enhanced circle formation by
ligation. The radioactively labeled transposon IR fragment
was incubated with T4 DNA ligase for different periods of
time. The experiment was performed using a low concentra-
tion of ligase and, under these conditions, no ligation products
were detected in the absence of HMGB1 even after 60 min of
incubation (Fig. 2, lane 5). In contrast, in the presence
of HMGB1, ligation products began to appear after 15 min of
incubation (lanes 8±10 in Fig. 2). Production of DNA circles
was veri®ed by treating the 60 min sample with ExoIII, which
cleaves linear DNA but leaves circular DNA intact. Two
ligation products were resistant to ExoIII treatment (Fig. 2,
lane 11), con®rming the presence of circular DNA molecules.
These results show that HMGB1 has a profound ability to
bend a DNA fragment containing the transposon IR.
A different assay was utilized to investigate HMGB1-
induced bending of a complete transposon. This assay is based
on circularization of linear DNA molecules by T4 DNA ligase,
and subsequent transformation into bacteria. Because of the
enhanced ability of circular DNA to transform E.coli,
the number of bacterial colonies serves as a measure of the
ef®ciency of the ligation reaction. An SB transposon contain-
ing zeo and an origin of replication was used for this
experiment (Fig. 3A). The linear transposon was treated with
T4 ligase in the absence and presence of HMGB1 for different
periods of time. As shown in Figure 3B, the average number of
bacterial colonies was signi®cantly higher in samples con-
taining HMGB1.
We conclude that HMGB1-induced bending has the poten-
tial to assist the SB transposase during synaptic complex
formation either by bringing the transposon binding sites and/
or the terminal repeats physically closer to each other.
HMGB1 enhances the DNA-binding activity of the SB
transposase
DNA transposition is a complex process that begins with
sequence-speci®c binding of the transposase to sites within the
transposon IRs. We hypothesized that, in addition to its DNA-
bending activity shown in Figures 2 and 3, HMGB1 stimulates
transposition by enhancing transposase binding to the IRs.
Histidine-tagged versions of both the N-terminal DNA-
binding domain of the SB transposase (N123) and HMGB1
Figure 2. HMGB1 enhances bending of the transposon IR. Intramolecular
ligation (circularization) assay was performed to monitor the effect of
HMGB1 on bending of the left IR of the transposon. The probe was ligated
by T4 DNA ligase in the absence or presence of HMGB1 for the time
periods indicated. Lane 11 is the same as lane 10, except treated with
ExoIII. Empty triangles indicate linear ligation products. Filled triangles
point to circular ligation products resistant to ExoIII digestion.
Figure 3. Bending effect of HMGB1 on a complete SB transposon.
(A) Schematic representation of the circularization assay. The SB transposon
contains zeo and a bacterial origin of replication (ORI). Black arrows ¯ank-
ing the element are the terminal IRs, white arrows inside the IRs are the
transposase binding sites. T4 ligase circularizes the linear transposon. The
effect of HMGB1 on T4 ligase-mediated circularization is measured by
transformation into E.coli cells, and counting bacterial colonies. (B) Effect
of HMGB1 on circle formation of SB transposon DNA. Shown are numbers
of bacterial colonies after transformation of DNA incubated with T4 ligase
in the presence and absence of HMGB1, for the time periods indicated.
Numbers are the average of three individual experiments.
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were puri®ed from E.coli using af®nity chromatography. The
left IR, containing two transposase-binding sites, was radio-
actively labeled and used as a probe in an EMSA (Fig. 4). As
shown previously (2), N123 produced two shifted bands,
representing complexes in which either one (complex C1) or
both sites (complex C2) are bound (Fig. 4A, lane 2). HMGB1
enhanced binding of N123, indicated by a more prominent
formation of C2 (Fig. 4A, lane 3). The enhancement was
inversely dependent on the concentration of N123 relative to
that of HMGB1; stimulation of binding was ~2-fold at 30 nM
N123 (Fig. 4A, lane 3), 5-fold at 15 nM N123 (Fig. 4A, lane
5), and >7-fold at 7.5 nM N123 (Fig. 4A, lane 7), as judged by
comparing the total bound radioactivity (sum of bands C1 and
C2) to the unbound, free probe in the presence and absence of
HMGB1. In this assay, HMGB1 alone did not shift the probe
when added at 75 nM concentration (data not shown).
HMGB1 did not produce a supershift either, indicating that
a ternary complex containing the DNA probe, N123 and
HMGB1 is unstable, at least under the conditions used in the
assay.
Next, the effect of HMGB1 on transposase binding to IR
probes carrying only a single transposase binding site was
tested in an EMSA. The ODR is located next to the
transposase cleavage site, whereas the IDR is ~200 bp from
the end of the transposon. The IDR and ODR are not identical,
they share ~80% sequence identity and the IDR is shorter by
2 bp (Fig. 4B). There appeared to be a clear preference for the
IDR in transposase binding, because N123 bound to it ~3-fold
stronger than to the ODR (compare lanes 2 and 6 in Fig. 4C).
The presence of HMGB1 appeared to further emphasize this
preference for IDR binding: at 75 nM concentration of
HMGB1, N123 shifted ~90% of the IDR probe (Fig. 4C, lane
8), but only ~50% of the ODR probe (Fig. 4C, lane 4).
HMGB1 alone did not shift either probe (Fig. 4C, lanes 3 and
7). Taken together, these data show that HMGB1 stimulates
transposase binding to the transposon IRs, and that it has a
more pronounced effect on binding to the IDR.
SB transposase physically interacts with HMGB1
Since HMGB1 has no sequence speci®city on its own, it has to
be actively recruited to speci®c sites by other DNA-binding
proteins (12). To investigate possible physical interactions
between the SB transposase and HMGB1, an immuno-
precipitation experiment was performed (Fig. 5). Nuclear
extracts were prepared from HeLa cells constitutively
expressing the SB transposase. An antibody against human
HMGB1 or a matched preimmune serum was used for
immunoprecipitation. Precipitated proteins were subsequently
blotted and hybridized with a polyclonal antibody against SB
transposase. SB transposase was coprecipitated with the
HMGB1 antibody, but not with the preimmune serum
(Fig. 5, lanes 1 and 2). Treating the nuclear extract with
DNase I did not in¯uence the formation of the immuno-
complex (compare lanes 2 and 3 in Fig. 5), indicating that the
detected signal was not due to non-speci®c, simultaneous
binding of SB and HMGB1 to genomic DNA. Furthermore,
interaction between HMGB1 and SB transposase is not
dependent on the presence of transposon DNA, because
immunoprecipitation in the presence or absence of DNA gave
similar results (data not shown). Control nuclear extracts did
not produce a signal (Fig. 5, lane 4); thus, immunoprecipita-
tion is dependent on the presence of SB transposase.
Treatment of nuclear extracts with actin and p15 antibodies
failed to immunoprecipitate SB transposase (Fig. 5, lanes 5
and 6), indicating that the interaction observed is speci®c for
Figure 4. HMGB1 stimulates speci®c binding of SB transposase to the
transposon IRs. (A) The effect of HMGB1 on transposase binding to the left
IR. EMSA was performed using the left IR of SB, containing two binding
sites for the transposase, as a probe, and N123, an N-terminal derivative of
SB transposase containing the speci®c DNA-binding domain. C1 and C2
indicate the two DNA±protein complexes formed in the assay.
(B) Comparison of SB transposase binding sites and the RAG1/2 recognition
signal sequences. The degrees of similarities to the heptamer and nonamer
motifs are indicated. (C) The effect of HMGB1 on binding to either the
outer or the inner transposase binding sites in the context of the left IR.
EMSA showing the stimulatory effects of HMGB1 on binding of N123 to
the ODR and IDR.
Figure 5. SB transposase interacts with HMGB1. Immunoblot of nuclear
extracts of HeLa cells expressing SB transposase, and control cells, after
incubation with antibodies against human HMGB1, actin and p15 proteins
or a preimmune serum, with or without DNase I treatment. The blot was
hybridized with an anti-SB antibody.
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HMGB1. Similar results were obtained when puri®ed
HMGB1 protein was immobilized on agarose beads, and
incubated with puri®ed SB protein (data not shown). We
conclude that the transposase actively interacts with HMGB1.
Formation of a ternary complex of transposon DNA, SB
transposase and HMGB1
The activity of HMGB1 at the transposon IRs necessitates the
temporary existence of a nucleoprotein complex containing
the transposon IRs, the transposase and HMGB1. We
considered that the full-length transposase protein is required
for either the formation or stability of such a complex.
Because production of recombinant, full-length SB transpo-
sase is dif®cult due to insolubility problems, a maltose-
binding protein±SB transposase fusion protein (MBP±SB) was
expressed in E.coli, and puri®ed. MBP±SB was ®rst tested for
DNA-binding activity in an EMSA experiment, using the
same IR probe as in Figure 4A. HMGB1 enhanced the binding
ef®ciency of MBP±SB more than two times (Fig. 6A, compare
lanes 2 and 3). HMGB1 alone did not shift the probe (Fig. 6A,
lane 4). The most ef®cient enhancement of DNA binding was
observed when HMGB1, MBP±SB and DNA were added to
the reaction at a molar ratio of 5:1:0.05 (Fig. 6A, lane 3 and
data not shown). We concluded that the MBP±SB fusion
protein was active in binding to the transposon IRs, and that,
as observed before, HMGB1 stimulated this binding.
Next we sought evidence for a ternary complex using
MBP±SB in a coimmunoprecipitation experiment. Radio-
actively labeled transposon IR DNA was incubated with
MBP±SB and HMGB1, and coimmunoprecipitated with either
anti-SB or anti-HMGB1 antibodies. Figure 6B shows that the
anti-SB antibody precipitated about three times more
DNA±transposase complexes when HMGB1 was present in
the reaction, consistent with our ®ndings that HMGB1
enhances binding of the transposase to transposon DNA.
The anti-HMGB1 antibody did not coimmunoprecipitate
DNA when MBP±SB or HMGB1 were added alone to the
probe. However, the anti-HMGB1 antibody did coimmuno-
precipitate DNA in the presence of both MBP±SB and
HMGB1 (Fig. 6B). In contrast, N123 was not able to form a
ternary complex (data not shown). These results show that
HMGB1 can form a ternary complex with MBP±SB and
transposon DNA. Because the catalytic steps of DNA
transposition require Mg2+ as a cofactor (27), and because
ternary complex formation in our experiments was observed in
a Mg2+-free buffer, we conclude that a likely role of HMGB1
in transposition is realized prior to catalysis, most likely
during synaptic complex assembly.
DISCUSSION
In this work we presented evidence that HMGB proteins are
cellular cofactors of SB transposition. In HMGB1 knockout
cells, transpositional activity was found to be marginal
(Fig. 1B). This residual activity can probably be accounted
for by the presence of HMGB2 in these cells (33). HMGB2
was found to partially or fully complement the absence of
HMGB1 in some reactions (12), so these two proteins are
interchangeable to a certain degree. Indeed, transient over-
expression of HMGB2 partially complemented the HMGB1
de®ciency in our transposition assays (Fig. 1B). Mammalian
cells contain signi®cant amounts of HMGBs; there might be
one molecule of HMGB1 for every 2 kb of the human genome
(35). Therefore, our ®nding that transient over-expression of
HMGBs in wild-type mouse cells enhances transposition
(Fig. 1B) was unexpected. However, this phenomenon is not
without precedent: transient over-expression of HMGB1 by
transfection enhances the activity of certain HMGB1 inter-
actors, such as RAG1/2 (24), some Hox proteins (21), and
nuclear hormone receptors (36). Our ®ndings suggest that
HMGB1 can be a limiting factor of SB transposition, and that
Figure 6. Formation of a ternary complex of the full-length SB transposase,
HMGB1, and transposon DNA. (A) HMGB1 stimulates speci®c binding of
a MBP±SB transposase fusion to the transposon IRs. EMSA was performed
using the left IR of SB, containing two binding sites for the transposase, as
a probe, and MBP±SB. The radioactively labeled IR fragment was incubated
with buffer only (lane 1), or with 20 nM MBP±SB alone (lane 2), or
together with 0.1 mM HMGB1 (lane 3). Lane 4 contained 0.1 mM HMGB1
alone. The arrow denotes the free probe. (B) Coimmunoprecipitation of
transposon±transposase complexes with SB and HMGB1 antibodies.
Puri®ed HMGB1 (1 mM) and puri®ed MBP±SB (0.2 mM) were incubated
individually or together with a radioactively labeled IR probe. Anti-SB and
anti-HMGB1 antibodies were used to coimmunoprecipitate labeled DNA
after incubation with MBP±SB and HMGB1 alone or together. After exten-
sive washing, the radioactivity of DNA bound to immunoabsorbent agarose
was measured by scintillation counting. The average c.p.m. values obtained
with the anti-SB antibody are the following: MBP±SB, 6946; MBP±SB plus
HMGB1, 23 033. The values with the anti-HMGB1 antibody are: MBP±SB,
2010; HMGB1, 2304; and MBP±SB plus HMGB1, 5473.
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different cellular levels of HMGB1 might modulate the
ef®ciency of transposition in different tissues or species.
Possible roles of HMGB1 in transposition
In prokaryotes, the DNA-bending proteins HU and IHF bind
directly to DNA, and no protein±protein interactions are
required for their targeting (7). In contrast, HMGs have low
af®nity for standard, B-form DNA, and interactor proteins
usually guide them to certain sites. We have shown that the SB
transposase is an HMG interactor (Figs 5 and 6). The
interaction was detectable in the absence of DNA, suggesting
that SB might actively recruit HMGB1 to sites of transpos-
ition. At which step is HMGB1 required for transposition? We
considered the following, not mutually exclusive, possibil-
ities: (i) HMGB1 induces a structural change in transposon
DNA, which is required for ef®cient transposition; (ii)
HMGB1 enhances binding of the transposase to the transposon
IRs; (iii) HMGB1 induces a conformational change of the
transposase that makes the transposase more active; (iv)
HMGB1 plays a role in transposon integration by making
contacts with chromatin components and/or by DNA-bending
at target sites (37). In this paper we provided evidence that
HMGB1 promotes circle formation of transposon DNA (Figs
2 and 3), that it signi®cantly enhances speci®c transposase
binding to the transposon IRs (Fig. 4), and that it can form a
ternary complex with the transposase and transposon DNA
(Fig. 6). Thus, although a role of HMGB1 in transposon
integration cannot be ruled out, our results are consistent with
a role of HMGB1 in the early steps of transposition, prior to
catalysis.
Considering the signi®cant drop of transposition activity in
HMGB1-de®cient cells (Fig. 1B), the role of HMGB1 in
transposition has to be a critical one. SB has four transposase-
binding sites, directly repeated at the ends of the terminal IRs.
We have previously shown that: (i) presence of the four
transposase binding sites is absolutely required for transpos-
ition (30) and (ii) SB transposase forms tetramers in complex
with transposase-binding sites (4). These observations are
consistent with an interaction between the IR/DR structure and
a transposase tetramer during transposition. We propose that
one of HMGB1's roles is to bring the two binding sites closer
to each other during synaptic complex formation (Fig. 7).
HMGB1 might promote communication between DNA motifs
that are otherwise distant to each other, including the DRs, the
transpositional enhancer and the two IRs (Fig. 7). Similar to
SB transposition, a DNA-bending protein, HU, is involved in
looping out the linker DNA between transposase binding sites
during Mu-transpososome assembly (7). If the only role of
HMGB1 is to extrude the spacer region between the DRs,
thereby bringing them close to each other in space, then
deleting the spacer would rescue transposition activity even in
the absence of HMGB1. We have constructed transposons, in
which the DRs were 10, 20 and 50 bp from each other. None of
these transposons had any detectable activity (data not
shown), indicating that physical proximity of the DRs is not
suf®cient for transposition, and that the correct geometrical
con®guration of the IRs and the binding sites is crucial.
These observations indicate that a highly speci®c con®g-
uration of functional DNA elements within the IRs has a
critical importance in SB transposition (Fig. 7). This complex
needs to be very precisely assembled, and probably includes
the four DRs, the HDR enhancer motif, four transposase
molecules (4) and HMGB1 (Fig. 7). Because transposase has
higher af®nity to the internal binding sites within the
transposon IRs (Fig. 4C), it appears that the order of events
that take place during the very early steps of transposition is
binding of transposase molecules ®rst to the inner sites, and
then to the outer sites. The pronounced effect of HMGB1 on
binding of the transposase to the inner sites suggests that
HMGB1 enforces ordered assembly of a catalytically active
synaptic complex. If any of these molecular requirements is
not ful®lled properly, the transposition reaction is hampered or
does not proceed at all. Indeed, replacement of the outer
transposase binding sites with the inner sites, i.e. increasing
binding at the outer sites, abolishes SB transposition (38). An
assembly pathway similar to the one we propose for SB has
been described for bacteriophage l. The integrase protein,
together with IHF, ®rst assembles on a high af®nity attach-
ment site (attP) on the phage genome (39), and then captures
another, low af®nity site on the bacterial chromosome (attB)
(40). In this system, the order of assembly is determined by the
difference in af®nity of the integrase for the attP and attB sites.
HMGB1 has overlapping, but distinct roles in V(D)J
recombination and SB transposition
In V(D)J recombination, the RAG1/2 complex speci®cally
binds to the nonamer and heptamer motifs of the RSSs
(Fig. 4B), which are separated by 12 or 23 bp spacer regions
(12/23-RSS). V(D)J recombination preferentially takes place
between a 12-RSS and a 23-RSS, which is termed the 12/23
rule (24,25,41). HMGB1/2 signi®cantly stimulates the binding
of both RSSs, but this stimulation is especially pronounced at
the 23-RSS (24). This selective enhancement of binding is
thought to enforce the speci®city of the subsequent cleavage
step (24,25). Recent results indicate that the RAG1/2 complex
®rst assembles on a single RSS, and that the partner RSS is
later incorporated into the complex as naked DNA (42). Initial
binding of RAG1/2 to the 12-RSS results in more faithful
adherence to the 12/23 rule. Because there is no substantial
Figure 7. A proposed model for the role of HMGB1 in SB synaptic
complex formation. SB transposase (gray spheres) recruits HMGB1 (dotted
hexagons) to the transposon IRs. First, HMGB1 stimulates speci®c binding
of the transposase to the IDRs. Once in contact with DNA, HMGB1 bends
the spacer regions between the DRs, thereby assuring correct positioning of
the ODRs for binding by the transposase. Cleavage (scissors) proceeds only
if complex formation is complete. The complex includes the four binding
sites (black boxes), the HDR enhancer sequence (black circle) and a tetra-
mer of the transposase.
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difference in the binding af®nity of RAG1/2 for naked 12- and
23-RSSs in the presence of HMGB proteins, it has been
suggested that chromatin structure may in¯uence whether
RAG1/2 binds ®rst to a 12- or a 23-RSS in vivo (42).
The transposase-binding sites of SB resemble the RSSs in
their sequence (Fig. 4B). Similarly to the RSSs, the spacing
between the nonamer and heptamer-like motifs within the
transposase-binding sites is different, 12 and 14 bps, in the
internal and external DRs, respectively. We have found that
SB transposase preferentially binds the IDR (12DR) (Fig. 4C).
The 2 bp difference in spacer length between 12DR and 14DR
might not be suf®cient for HMGB1 to assert its DNA-bending
activity to promote transposase binding. More likely, the
helical phasing of the heptamer- and nonamer-like sequences
in 14DR might be less favorable for transposase binding. In
contrast to V(D)J recombination, the original preference of the
SB transposase for binding to the 12DR is not altered, but even
further emphasized in the presence of HMGB1 (Fig. 4C). In
conclusion, HMGB1 seems to have overlapping, but distinct
roles in SB transposition and in V(D)J recombination.
The IR/DR-type organization of IRs is an evolutionarily
conserved feature of many transposons in the Tc1 family (1),
but its function in transposition has been enigmatic. Our
results suggest that the IR/DR introduces a higher level
regulation into the transposition process: the repeated
transposase binding sites, their dissimilar af®nity for the
transposase, and the effect of HMGB1 to differentially
enhance transposase binding to the inner sites are all important
for a geometrically and timely orchestrated formation of
synaptic complexes, which is a strict requirement for the
subsequent catalytic steps of transposition.
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